Brief: Amyris Inc And Immunitybio Complete JV For Covid-19 Rna Vaccine
03/01/2022 13:51
Jan 3 (Reuters) - Amyris Inc AMRS.O :
* AMYRIS INC - CO AND IMMUNITYBIO COMPLETE JV FOR NEXT
GENERATION
COVID-19 RNA VACCINE
* AMYRIS INC - JV'S GOAL IS TO START DELIVERING SECOND
GENERATION
VACCINE IN 2022 AS SOON AS IS PRACTICALLY POSSIBLE
* AMYRIS INC - FOCUSED ON COMPLETING HUMAN TRIALS AND
DELIVERING
VACCINES IN 2022
Source text for Eikon: ID:nPn2FLnJva
Further company coverage: AMRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amyris
See all newsBrief: Amyris Announces Kathy Fortmann As New CEO
Brief: Amyris Announced Termination Or Separation Of About 80 Employees on Feb 7
Brief: Amyris- Related To Sale Of Some Consumer Brands, Announces Termination/ Separation Of About 220 Employees
Brief: Amyris On December 12, Debtors Entered Into An Amendment To And Restatement Of That Certain Plan Support Agreement, Dated October 12, 2023
Brief: Amyris Inc On August 10, Received Notice Of Delisting From Nasdaq